Searched for
NOVO NORDISK PATENT EXPIRATION
Holiday Halt: S&P 500, Nasdaq to remain closed for Juneteenth today after busy 'triple witching' sessionUS financial markets will be closed on Friday, June 19, for Juneteenth, granting investors a long weekend. This federal holiday's observanc...- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- Qatar introduces new residency rule: What foreign workers need to knowQatar has cut the exit window for foreign workers after residence permit cancellation to just two weeks. Previously, workers had 30 days to...
- US quietly allows waiver on Russian oil to expireAmerica's Treasury has not extended sanctions waivers on Russian oil. This waiver expired at midnight. President Trump has not confirmed if...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- UK extends deadline for migrants to replace physical immigration documents with e-visasThe UK has extended the validity of expired Biometric Residence Permits (BRPs) and Biometric Residence Cards (BRCs) for accessing immigrati...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- US district court rejects patent claims against Hexaware TechnologiesA US district court dismissed patent infringement claims against Hexaware Technologies, ruling that Natsoft Corporation's asserted patents ...
- Jio enters global top 20 list in WIPO patent rankingsJio Platforms has surged into the global top 20 of WIPO's PCT rankings, a remarkable leap of 320 positions. This achievement highlights Jio...
- European shares rally as Middle East peace hopes drag oil prices lowerEuropean shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Global Market | European stocks rally as oil falls on hopes for US-Iran dealThe benchmark snapped a four-day losing streak on Thursday, as investors digested the European Central Bank's rate hike and largely looked...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Novo Nordisk hit by cyber incident, probes data breachDanish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...
- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Novo Holdings commits 500 million euros in new European tech growth fundNovo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
Load More
